Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
Abstract Background Adalimumab in combination with other disease-modifying antirheumatic drugs (DMARD) such as methotrexate has a proven efficacy in the management of paediatric non-infectious uveitis. However, many children experience significant intolerance to methotrexate while on this combinatio...
Main Authors: | DA Al-Julandani, NK Bagri, N Tsang, S Clarke, A Upadhyay, C Guly, AV Ramanan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Pediatric Rheumatology Online Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12969-023-00794-y |
Similar Items
-
The effectiveness of adalimumab treatment for non-infectious uveitis
by: Eiichi Hasegawa, et al.
Published: (2019-04-01) -
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
by: Tomona Hiyama, et al.
Published: (2019-06-01) -
Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy
by: Megan Cann, et al.
Published: (2018-08-01) -
Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis
by: Weishai Liu, et al.
Published: (2023-05-01) -
Persistence of Juvenile Idiopathic Arthritis-Associated Uveitis in Adulthood: A Retrospective Study
by: Maria Pia Paroli, et al.
Published: (2022-04-01)